Login / Signup

The synergistic efficacy of hydroxychloroquine with methotrexate is accompanied by increased erythrocyte mean corpuscular volume.

Muhammad Ruhu Amin ShipaSu-Ann YeohAndrew Embleton-ThirskDev MukerjeeMichael R Ehrenstein
Published in: Rheumatology (Oxford, England) (2021)
Our data provides mechanistic insight into the synergistic clinical benefit of concomitant hydroxychloroquine with methotrexate, boosting the rise in MCV which could serve as a companion biomarker of treatment response.
Keyphrases
  • high dose
  • cancer therapy
  • electronic health record
  • big data
  • deep learning